Cargando…

Complementary therapies for clinical depression: an overview of systematic reviews

OBJECTIVES: As clinical practice guidelines vary widely in their search strategies and recommendations of complementary and alternative medicine (CAM) for depression, this overview aimed at systematically summarising the level 1 evidence on CAM for patients with a clinical diagnosis of depression. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Haller, Heidemarie, Anheyer, Dennis, Cramer, Holger, Dobos, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686993/
https://www.ncbi.nlm.nih.gov/pubmed/31383703
http://dx.doi.org/10.1136/bmjopen-2018-028527
_version_ 1783442656469188608
author Haller, Heidemarie
Anheyer, Dennis
Cramer, Holger
Dobos, Gustav
author_facet Haller, Heidemarie
Anheyer, Dennis
Cramer, Holger
Dobos, Gustav
author_sort Haller, Heidemarie
collection PubMed
description OBJECTIVES: As clinical practice guidelines vary widely in their search strategies and recommendations of complementary and alternative medicine (CAM) for depression, this overview aimed at systematically summarising the level 1 evidence on CAM for patients with a clinical diagnosis of depression. METHODS: PubMed, PsycInfo and Central were searched for meta-analyses of randomised controlled clinical trials (RCTs) until 30 June 2018. Outcomes included depression severity, response, remission, relapse and adverse events. The quality of evidence was assessed according to Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) considering the methodological quality of the RCTs and meta-analyses, inconsistency, indirectness, imprecision of the evidence and the potential risk of publication bias. RESULTS: The literature search revealed 26 meta-analyses conducted between 2002 and 2018 on 1–49 RCTs in major, minor and seasonal depression. In patients with mild to moderate major depression, moderate quality evidence suggested the efficacy of St. John’s wort towards placebo and its comparative effectiveness towards standard antidepressants for the treatment for depression severity and response rates, while St. John’s wort caused significant less adverse events. In patients with recurrent major depression, moderate quality evidence showed that mindfulness-based cognitive therapy was superior to standard antidepressant drug treatment for the prevention of depression relapse. Other CAM evidence was considered as having low or very low quality. CONCLUSIONS: The effects of all but two CAM treatments found in studies on clinical depressed patients based on low to very low quality of evidence. The evidence has to be downgraded mostly due to avoidable methodological flaws of both the original RCTs and meta-analyses not following the Consolidated Standards of Reporting Trials and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Further research is needed.
format Online
Article
Text
id pubmed-6686993
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66869932019-08-23 Complementary therapies for clinical depression: an overview of systematic reviews Haller, Heidemarie Anheyer, Dennis Cramer, Holger Dobos, Gustav BMJ Open Complementary Medicine OBJECTIVES: As clinical practice guidelines vary widely in their search strategies and recommendations of complementary and alternative medicine (CAM) for depression, this overview aimed at systematically summarising the level 1 evidence on CAM for patients with a clinical diagnosis of depression. METHODS: PubMed, PsycInfo and Central were searched for meta-analyses of randomised controlled clinical trials (RCTs) until 30 June 2018. Outcomes included depression severity, response, remission, relapse and adverse events. The quality of evidence was assessed according to Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) considering the methodological quality of the RCTs and meta-analyses, inconsistency, indirectness, imprecision of the evidence and the potential risk of publication bias. RESULTS: The literature search revealed 26 meta-analyses conducted between 2002 and 2018 on 1–49 RCTs in major, minor and seasonal depression. In patients with mild to moderate major depression, moderate quality evidence suggested the efficacy of St. John’s wort towards placebo and its comparative effectiveness towards standard antidepressants for the treatment for depression severity and response rates, while St. John’s wort caused significant less adverse events. In patients with recurrent major depression, moderate quality evidence showed that mindfulness-based cognitive therapy was superior to standard antidepressant drug treatment for the prevention of depression relapse. Other CAM evidence was considered as having low or very low quality. CONCLUSIONS: The effects of all but two CAM treatments found in studies on clinical depressed patients based on low to very low quality of evidence. The evidence has to be downgraded mostly due to avoidable methodological flaws of both the original RCTs and meta-analyses not following the Consolidated Standards of Reporting Trials and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Further research is needed. BMJ Publishing Group 2019-08-05 /pmc/articles/PMC6686993/ /pubmed/31383703 http://dx.doi.org/10.1136/bmjopen-2018-028527 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Complementary Medicine
Haller, Heidemarie
Anheyer, Dennis
Cramer, Holger
Dobos, Gustav
Complementary therapies for clinical depression: an overview of systematic reviews
title Complementary therapies for clinical depression: an overview of systematic reviews
title_full Complementary therapies for clinical depression: an overview of systematic reviews
title_fullStr Complementary therapies for clinical depression: an overview of systematic reviews
title_full_unstemmed Complementary therapies for clinical depression: an overview of systematic reviews
title_short Complementary therapies for clinical depression: an overview of systematic reviews
title_sort complementary therapies for clinical depression: an overview of systematic reviews
topic Complementary Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686993/
https://www.ncbi.nlm.nih.gov/pubmed/31383703
http://dx.doi.org/10.1136/bmjopen-2018-028527
work_keys_str_mv AT hallerheidemarie complementarytherapiesforclinicaldepressionanoverviewofsystematicreviews
AT anheyerdennis complementarytherapiesforclinicaldepressionanoverviewofsystematicreviews
AT cramerholger complementarytherapiesforclinicaldepressionanoverviewofsystematicreviews
AT dobosgustav complementarytherapiesforclinicaldepressionanoverviewofsystematicreviews